Longevity

Peptide Therapy: What You Need to Know

A comprehensive guide to peptide therapy—BPC-157, TB-500, growth hormone secretagogues, and more. What the science says, what's legal, and what you should know before trying them.

Last updated: January 2025 • 18 min read

⚠️

Critical Regulatory Information

Most peptides discussed here are NOT FDA-approved medications. In late 2023, the FDA moved many popular peptides (including BPC-157, TB-500, and some growth hormone secretagogues) to Category 2 of its "Bulk Drug Substances" list, effectively restricting their use even by compounding pharmacies. The legal and safety landscape is rapidly evolving.

Peptide Therapy Overview

Cost Range
$150 - $500+/month
Depending on peptide(s)
Administration
Mostly injectable
Some oral/nasal options
Evidence Level
Mixed
Mostly animal/cell studies

Peptide therapy has become one of the hottest trends in biohacking and longevity medicine. Athletes swear by them for recovery, anti-aging clinics promote them for everything from healing to fat loss, and they've become a multi-hundred-million dollar industry. But what's real, what's hype, and what's the legal reality?

What Are Peptides?

Peptides are short chains of amino acids—essentially small proteins. Your body makes thousands of peptides naturally, and they serve as signaling molecules that regulate various biological processes.

"Peptide therapy" typically refers to using synthetic versions of these signaling molecules to achieve specific effects: accelerating healing, building muscle, improving sleep, or stimulating growth hormone.

Important distinction: Peptides are different from anabolic steroids. They work through signaling pathways rather than directly forcing hormonal changes. However, some (like growth hormone secretagogues) do affect hormone levels.

Healing & Recovery Peptides

BPC-157 (Body Protection Compound)

What it is: A synthetic peptide based on a protective compound found in gastric juice.

Claimed benefits: Accelerated healing of tendons, ligaments, muscles, and gut tissue. Often called the "Wolverine peptide" for supposed rapid healing.

Administration: Subcutaneous injection near injury site, or oral/sublingual.

Typical dose: 250-500mcg 1-2x daily

Cost: $80-150/month

TB-500 (Thymosin Beta-4)

What it is: Synthetic version of a naturally occurring protein involved in tissue repair.

Claimed benefits: Promotes new blood vessel growth, reduces inflammation, supports healing. Often stacked with BPC-157.

Administration: Subcutaneous or intramuscular injection.

Typical dose: 2-5mg 1-2x weekly

Cost: $100-200/month

Growth Hormone Secretagogues

These peptides stimulate your pituitary gland to produce more growth hormone naturally, rather than injecting synthetic HGH directly.

CJC-1295 (with or without DAC)

What it is: Growth hormone releasing hormone (GHRH) analog.

Claimed benefits: Increases growth hormone levels, may improve body composition, sleep, and recovery.

Administration: Subcutaneous injection, often before bed.

Cost: $150-300/month

Ipamorelin

What it is: Growth hormone secretagogue (GHS) that stimulates the ghrelin receptor.

Claimed benefits: Selective GH release without affecting cortisol or prolactin. Often combined with CJC-1295.

Administration: Subcutaneous injection, usually before bed.

Cost: $100-200/month

Tesamorelin

What it is: GHRH analog—notably, the only FDA-approved peptide in this category.

FDA-approved for: Reducing abdominal fat in HIV patients with lipodystrophy.

Off-label use: Body composition, anti-aging. This is the one GH peptide you can legally get prescribed.

Cost: $400-800/month (expensive due to FDA approval)

Other Notable Peptides

PeptidePrimary UseNotes
PT-141 (Bremelanotide)Sexual dysfunctionFDA-approved as Vyleesi for female HSDD
Melanotan IITanning, libidoNOT FDA-approved; significant safety concerns
SelankAnxiety, cognitionApproved in Russia, not US
SemaxCognitive enhancementApproved in Russia, not US
GHK-CuSkin, wound healingCopper peptide; topical and injectable
EpithalonLongevity (telomeres)Heavily marketed but weak evidence

What Does the Science Say?

Here's the honest assessment of the evidence for popular peptides:

BPC-157: Promising in Animals, Unproven in Humans

  • Dozens of animal studies showing accelerated healing of various tissues
  • Works through multiple mechanisms: angiogenesis, growth factors, gut-brain axis
  • But: Almost no controlled human trials published
  • Anecdotal reports are extremely positive, but this is weak evidence
  • Systematic reviews conclude more research is needed

TB-500: Similar Story

  • Strong mechanistic rationale and animal data
  • Used extensively in veterinary medicine (racehorses)
  • But: Very limited human studies
  • The one human wound-healing study was small and inconclusive

Growth Hormone Secretagogues: Better Evidence

  • CJC-1295 and Ipamorelin: Small human studies confirm they do raise GH/IGF-1
  • Tesamorelin: Well-studied with FDA approval for specific use
  • Whether raising GH provides meaningful benefits for healthy adults is debated
  • Long-term safety data in healthy populations is limited

The Evidence Gap

The peptide industry is built largely on: (1) animal studies, (2) mechanistic plausibility, and (3) anecdotes. While some peptides may genuinely work, we don't have the rigorous human clinical trial data that would typically be required to make health claims. This doesn't mean they don't work—it means we don't know for certain.

Legal & Regulatory Status

The regulatory landscape for peptides changed dramatically in 2023-2024:

The FDA's Category 2 List

In late 2023, the FDA finalized a rule moving numerous peptides to "Category 2" of its bulk drug substances list. Category 2 means these peptides cannot be used by compounding pharmacies to make patient-specific medications.

Peptides Restricted by FDA (Category 2)

  • • BPC-157
  • • TB-500 (Thymosin Beta-4)
  • • AOD-9604
  • • CJC-1295 (both versions)
  • • Ipamorelin
  • • Sermorelin
  • • GHRP-2, GHRP-6
  • • Epithalon

What This Means Practically

  • Licensed US pharmacies can no longer legally compound these peptides
  • Doctors cannot legally prescribe them from compounding pharmacies
  • "Research chemical" websites still sell them, but this is a legal gray area
  • Quality and contamination risks increase with unregulated sources

Peptides That Are Still Available

  • Tesamorelin: FDA-approved, available by prescription
  • PT-141 (Bremelanotide): FDA-approved as Vyleesi
  • Semaglutide/Tirzepatide: FDA-approved GLP-1 medications
  • GHK-Cu: Currently not restricted for cosmetic use

How People Get Peptides

Before 2024 (Historical)

  • Telehealth clinics: Prescribed via online consultation, filled by compounding pharmacies
  • Anti-aging/longevity clinics: In-person or telemedicine prescriptions
  • Compounding pharmacies: Made patient-specific preparations

Current Reality (Post-FDA Restrictions)

  • "Research chemical" vendors: Sell peptides labeled "not for human consumption"
  • International pharmacies: Some people order from overseas
  • Underground sources: Quality completely unverified

Quality & Safety Concerns

With FDA restrictions pushing the market underground, quality concerns have increased significantly:

  • • Third-party testing shows many products are mislabeled or contaminated
  • • Some "peptides" contain little to no active ingredient
  • • Bacterial contamination is a real risk with injectable products
  • • No recourse if products cause harm

Risks & Side Effects

General Injection Risks

  • Injection site reactions (redness, swelling, pain)
  • Infection risk (if contaminated product or poor technique)
  • Abscess formation

Peptide-Specific Concerns

Growth hormone secretagogues:

  • Water retention, joint pain
  • Potential for glucose intolerance
  • Theoretical cancer concerns (GH promotes cell growth)
  • Unknown long-term effects

BPC-157:

  • Generally well-tolerated in animal studies
  • Theoretical concern: promoting blood vessel growth could affect tumors
  • Unknown long-term human effects

Melanotan II:

  • Nausea, flushing, appetite suppression
  • Changes to moles (potential melanoma risk)
  • Uncontrolled erections in men
  • The FDA has issued explicit warnings about this one

Our Assessment

The Balanced View

Peptides are genuinely interesting molecules with real biological effects. Some may truly help with healing, body composition, or performance. The science is plausible and animal data is often impressive.

However:

  • Human clinical trial data is largely missing
  • The FDA has restricted most popular peptides, making legal access difficult
  • Unregulated sources pose real quality and safety risks
  • Long-term effects are unknown
  • Marketing claims often far exceed evidence

When Peptides Might Make Sense

  • FDA-approved options (Tesamorelin, PT-141) with physician supervision
  • You've exhausted conventional treatment options
  • You understand you're experimenting with uncertain benefits
  • You can verify product quality (challenging now)
  • You're working with a knowledgeable physician

When to Skip Them

  • You're expecting guaranteed results
  • You'd be using unverified sources
  • You have a history of cancer (especially with GH peptides)
  • You're not comfortable with the legal/regulatory uncertainty
  • You haven't optimized the basics (sleep, nutrition, training)

Exploring Longevity Options?

Learn about other longevity interventions and their evidence base.

Longevity Hub

Important Disclaimer

Most peptides discussed in this guide are NOT FDA-approved for human use. Their sale, purchase, and use may violate federal and state laws. This information is for educational purposes only and does not constitute medical advice, legal advice, or encouragement to use any peptide.

The FDA has explicitly warned against the use of many peptides. Using products from unregulated sources carries significant health risks. Consult with a licensed healthcare provider before considering any peptide therapy.

Sources & References

  • • FDA Final Rule: Bulk Drug Substances That Can Be Used To Compound Drug Products (2023)
  • • Sikiric et al. - Multiple BPC-157 studies in Journal of Physiology and Pharmacology
  • • Tesamorelin FDA approval documents and clinical trial data
  • • Endocrine Society: Position on growth hormone secretagogues
  • • Journal of Clinical Endocrinology: GH secretagogue studies

Get Our Peptide Therapy Research Guide

BPC-157, TB-500, and more: evidence summaries, sourcing tips, and protocol guides.

No spam, unsubscribe anytime.